We are live on ! Find out more
BMA

Brooks Moore & Associates Portfolio holdings

AUM $199M
1-Year Est. Return 21.09%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+21.09%
3 Year Est. Return
+57.25%
5 Year Est. Return
+77.34%
10 Year Est. Return
AUM
$157M
AUM Growth
+$9.17M
Cap. Flow
+$3.31M
Cap. Flow %
2.11%
Top 10 Hldgs %
29.2%
Holding
105
New
8
Increased
35
Reduced
28
Closed
3

Top Buys

Rank Stock Value
1
WPC icon
W.P. Carey
WPC
+$1.07M
2
OGN icon
Organon & Co
OGN
+$708K
3
INTC icon
Intel
INTC
+$466K
4
VZ icon
Verizon
VZ
+$455K
5
MRK icon
Merck
MRK
+$317K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$1.17M
2
KO icon
Coca-Cola
KO
+$489K
3
DD icon
DuPont de Nemours
DD
+$483K
4
LOW icon
Lowe's Companies
LOW
+$284K
5
KMB icon
Kimberly-Clark
KMB
+$226K

Sector Composition

Rank Sector Weight
1 Healthcare 15.74%
2 Technology 15.18%
3 Financials 11.37%
4 Consumer Staples 11.36%
5 Industrials 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.92T
$7.03M 4.48%
25,946
-475
-2% -$121K
ABT icon
2
Abbott
ABT
$183B
$5.41M 3.45%
46,622
+300
+0.6% +$35K
ABBV icon
3
AbbVie
ABBV
$457B
$4.95M 3.16%
43,973
-375
-0.8% -$42.2K
JNJ icon
4
Johnson & Johnson
JNJ
$645B
$4.92M 3.14%
29,894
+44
+0.1% +$7.28K
VZ icon
5
Verizon
VZ
$198B
$4.58M 2.92%
81,700
+7,934
+11% +$455K
AAPL icon
6
Apple
AAPL
$4.93T
$4.04M 2.58%
29,533
+58
+0.2% +$7.51K
JPST icon
7
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$3.88M 2.47%
76,365
-250
-0.3% -$12.7K
MRK icon
8
Merck
MRK
$324B
$3.73M 2.38%
48,012
+4,268
+10% +$317K
XOM icon
9
ExxonMobil
XOM
$641B
$3.67M 2.34%
58,209
+3,475
+6% +$207K
TFC icon
10
Truist Financial
TFC
$63.5B
$3.56M 2.27%
64,113
+3,015
+5% +$177K
HD icon
11
Home Depot
HD
$336B
$3.54M 2.26%
11,111
KO icon
12
Coca-Cola
KO
$361B
$3.52M 2.25%
65,039
-8,980
-12% -$489K
QCOM icon
13
Qualcomm
QCOM
$178B
$3.48M 2.22%
24,350
+750
+3% +$101K
HON icon
14
Honeywell
HON
$77.3B
$3.47M 2.21%
16,780
-106
-0.6% -$22.4K
CSCO icon
15
Cisco
CSCO
$451B
$3.45M 2.2%
65,110
+2,060
+3% +$108K
LMT icon
16
Lockheed Martin
LMT
$135B
$3.37M 2.15%
8,894
-80
-0.9% -$30.8K
CVX icon
17
Chevron
CVX
$381B
$3.36M 2.14%
32,050
+1,790
+6% +$189K
PEP icon
18
PepsiCo
PEP
$191B
$3.27M 2.08%
22,034
+725
+3% +$106K
GOOGL icon
19
Alphabet (Google) Class A
GOOGL
$4T
$3.21M 2.05%
26,300
-1,080
-4% -$126K
PG icon
20
Procter & Gamble
PG
$347B
$3.06M 1.95%
22,693
+1,939
+9% +$262K
JPM icon
21
JPMorgan Chase
JPM
$944B
$3.05M 1.94%
19,588
+462
+2% +$72.6K
INTC icon
22
Intel
INTC
$460B
$2.97M 1.9%
52,919
+7,937
+18% +$466K
PFF icon
23
iShares Preferred and Income Securities ETF
PFF
$13.2B
$2.73M 1.74%
69,532
+5,550
+9% +$215K
UPS icon
24
United Parcel Service
UPS
$95.9B
$2.73M 1.74%
13,149
+85
+0.7% +$17K
GIS icon
25
General Mills
GIS
$19.6B
$2.61M 1.67%
42,887
+1,750
+4% +$108K

Similar funds

Brooks Moore & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Brooks Moore & Associates held 105 positions worth $157M, up 6.2% from $148M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Brooks Moore & Associates's Q2 2021 filing shows 8 new, 35 increased, 28 reduced and 3 closed positions. Its largest new stake was W.P. Carey: 14,677 shares worth $1.07M. The largest sale was AT&T, an estimated $1.17M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Brooks Moore & Associates's largest Q2 2021 buy was W.P. Carey: 14,677 shares worth $1.07M.
  • Brooks Moore & Associates added most to Intel in Q2 2021, an estimated $466K increase.
  • Brooks Moore & Associates's biggest Q2 2021 reduction was Coca-Cola, cutting an estimated $489K.
  • Brooks Moore & Associates fully exited AT&T in Q2 2021, selling an estimated $1.17M.
  • Brooks Moore & Associates's ten largest holdings make up 29% of its $157M portfolio in Q2 2021.
  • Brooks Moore & Associates opened 8 new positions and closed 3 in Q2 2021.
  • Brooks Moore & Associates's portfolio value rose 6.2% quarter-over-quarter to $157M.

Based on Brooks Moore & Associates's 13F filing for Q2 2021, filed 21 Jul 2021.